Horst-Dieter Hummel, Myung-Ju Ahn, Fiona Blackhall, Martin Reck, Hiroaki Akamatsu, Suresh S. Ramalingam et al. Patient-Reported Outcomes for Patients with Previously Treated Small Cell Lung Cancer Receiving Tarlatamab: Results from the DeLLphi-301 Phase 2 Trial. // Advances in Therapy. – 2025. – DOI: 10.1007/s12325-025-03136-4. – URL: https://doi.org/10.1007/s12325-025-03136-4
Horst-Dieter Hummel, Myung-Ju Ahn, Fiona Blackhall, Martin Reck, Hiroaki Akamatsu, Suresh S. Ramalingam, Hossein Borghaei, Melissa Johnson, Franziska Dirnberger, Kim Cocks, Shuang Huang, Sujoy Mukherjee, & Luis Paz-Ares (2025). Patient-Reported Outcomes for Patients with Previously Treated Small Cell Lung Cancer Receiving Tarlatamab: Results from the DeLLphi-301 Phase 2 Trial. Advances in Therapy. https://doi.org/10.1007/s12325-025-03136-4
Horst-Dieter Hummel, et al. “Patient-Reported Outcomes for Patients with Previously Treated Small Cell Lung Cancer Receiving Tarlatamab: Results from the DeLLphi-301 Phase 2 Trial.” Advances in Therapy, 2025. doi:10.1007/s12325-025-03136-4.
@article{Hummel2025,
title = {Patient-Reported Outcomes for Patients with Previously Treated Small Cell Lung Cancer Receiving Tarlatamab: Results from the DeLLphi-301 Phase 2 Trial},
author = {Hummel, Horst-Dieter and Ahn, Myung-Ju and Blackhall, Fiona and Reck, Martin and Akamatsu, Hiroaki and Ramalingam, Suresh S. and Borghaei, Hossein and Johnson, Melissa and Dirnberger, Franziska and Cocks, Kim and Huang, Shuang and Mukherjee, Sujoy and Paz-Ares, Luis},
journal = {Advances in Therapy},
year = {2025},
doi = {10.1007/s12325-025-03136-4},
url = {https://doi.org/10.1007/s12325-025-03136-4}
}